908 Devices (MASS) Cash from Financing Activities (2020 - 2026)
908 Devices (MASS) reported Cash from Financing Activities of -$2.2 million for Q1 2026, down 1047.09% year-over-year from $228911.7 in Q1 2025, and down 423.67% on a QoQ basis from -$414000.0 in Q4 2025.
908 Devices (MASS) has 7 years of Cash from Financing Activities data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 1047.09% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 million (down 466.58% YoY) and the FY2025 annual result came in at -$697000.0, down 85.37% from the prior year.
- Cash from Financing Activities eased to -$2.2 million in Q1 2026 per MASS's latest filing, from -$414000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $529000.0 in Q4 2024 and bottomed at -$15.4 million in Q1 2023.
- The 5-year median for Cash from Financing Activities is -$16000.0 (2025), against an average of -$1.1 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities plunged 11931.54%; it then jumped 456.84% in 2024.
- Tracing MASS's Cash from Financing Activities over 5 years: stood at $411000.0 in 2022, then plunged by 76.89% to $95000.0 in 2023, then jumped by 456.84% to $529000.0 in 2024, then plunged by 178.26% to -$414000.0 in 2025, then plunged by 423.67% to -$2.2 million in 2026.
- Per Business Quant, the three latest MASS Cash from Financing Activities figures stand at -$2.2 million (Q1 2026), -$414000.0 (Q4 2025), and -$16000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | -2.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.17 Mn |
| Mar 31, 2026 | -2.17 Mn |
| Dec 31, 2025 | -414,000.00 |
| Dec 31, 2025 | -414,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | -78,000.00 |
| Jun 30, 2025 | -78,000.00 |
| Mar 31, 2025 | -189,000.00 |
| Mar 31, 2025 | -189,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 367,000.00 |
| Mar 31, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | 95,000.00 |
| Dec 31, 2023 | 95,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Jun 30, 2023 | -401,000.00 |
| Jun 30, 2023 | -401,000.00 |
| Mar 31, 2023 | -15.38 Mn |
| Mar 31, 2023 | -15.38 Mn |
| Dec 31, 2022 | 411,000.00 |
| Dec 31, 2022 | 411,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Jun 30, 2022 | 467,000.00 |
| Jun 30, 2022 | 467,000.00 |
| Mar 31, 2022 | 130,000.00 |
| Mar 31, 2022 | 130,000.00 |
| Dec 31, 2021 | 94.53 Mn |
| Dec 31, 2021 | 94.53 Mn |
| Sep 30, 2021 | 483,000.00 |
| Sep 30, 2021 | 483,000.00 |
| Jun 30, 2021 | 276,000.00 |
| Jun 30, 2021 | 276,000.00 |
| Mar 31, 2021 | -566,000.00 |
| Mar 31, 2021 | -566,000.00 |
| Dec 31, 2020 | 137.18 Mn |
| Dec 31, 2020 | 137.18 Mn |
| Sep 30, 2020 | 5,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |